Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 16;19(1):131.
doi: 10.1186/s13065-025-01489-z.

Fe3O4@SiO2-SnCl4-promoted synthesis, cytotoxic evaluation, molecular docking, and MD simulation of some indenopyrido[2,3-d]pyrimidine derivatives

Affiliations

Fe3O4@SiO2-SnCl4-promoted synthesis, cytotoxic evaluation, molecular docking, and MD simulation of some indenopyrido[2,3-d]pyrimidine derivatives

Leila Emami et al. BMC Chem. .

Abstract

In this study, an efficient and environmentally friendly method for the one-pot synthesis of indenopyrido[2,3-d]pyrimidine derivatives was developed using Fe3O4@SiO2-SnCl4 nanoparticles as a catalyst. Indenopyrido[2,3-d]pyrimidines (4a-4j) were synthesized via three-component couplings of 6-amino-2-(methylthio)pyrimidin-4(3H)-one, 1,3-indanedione, and aldehydes in water as the solvent. In this reaction, Fe3O4@SiO2-SnCl4 demonstrated a highly catalytic nature, an easy handling procedure, short reaction times, recyclability exploitation, and excellent yields. The cytotoxic activities of the synthesized indenopyrido[2,3-d] pyrimidines analogues were evaluated against three cancer cell lines; MCF-7 (breast carcinoma), A549 (lung non-small cell carcinoma), and SKOV3 (ovarian carcinoma) using MTT assay. Additionally, molecular docking studies and molecular dynamics (MD) simulation of the investigated compounds was performed to verify their binding modes toward EGFR kinase receptor as the possible targets. This analysis aimed to predict the antitumor mechanisms of the synthesized compounds. The binding free energy values of the compounds showed a satisfactory correlation with their cytotoxic activities.

Keywords: Cytotoxic activity; Indenopyrido[2,3-d]pyrimidine; MD Simulation; Molecular docking.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Indeno [1, 2-d] pyrimidine and pyrido[2,3-d]pyrimidines derivatives with anticancer activity
Fig. 2
Fig. 2
Synthesis of indenopyrido[2,3-d]pyrimidines (4a–4j)
Fig. 3
Fig. 3
Proposed mechanism for the synthesis of indenopyrido[2,3-d]pyrimidines in the presence of Fe3O4@SiO2-SnCl4
Fig. 4
Fig. 4
The main interaction of Erlotinib (yellow) and 4f (pink) in the active site of EGFR (PDB ID: 1M17)
Fig. 5
Fig. 5
The structure of 4i surrounded by the key residue in the active site of EGFR
Fig. 6
Fig. 6
The interaction and binding mode of 4f and 4i in the active site of estrogen receptor alpha (ERα) (PDB ID: 3ERT)
Fig. 7
Fig. 7
RMSD of the total system during simulation time
Fig. 8
Fig. 8
RMSF analysis of the protein backbone atoms of the 1M17 in complexes with 4f and 4c ligands
Fig. 9
Fig. 9
Radius of gyration during the simulation process
Fig. 10
Fig. 10
Number of hydrogen bonds between ligands and protein through simulation time

References

    1. Zheng L-W, et al. Synthesis of novel oxime-containing pyrazole derivatives and discovery of regulators for apoptosis and autophagy in A549 lung cancer cells. Bioorg Med Chem Lett. 2010;20(16):4766–70. - PubMed
    1. Patrick GL. An introduction to medicinal chemistry. Oxford: Oxford University Press; 2013.
    1. Kang L, et al. Structure–activity relationship investigation of coumarin–chalcone hybrids with diverse side-chains as acetylcholinesterase and butyrylcholinesterase inhibitors. Mol Diversity. 2018;22:893–906. - PMC - PubMed
    1. DeGraw JI, et al. Antimicrobial activity of 8-deazafolic acid. J Med Chem. 1974;17(4):470–1. - PubMed
    1. Matsumoto J, Minami S. Pyrido [2, 3-d] pyrimidine antibacterial agents 3 8-alkyl-and 8-vinyl-5, 8-dihydro-5-oxo-2-(1-piperazinyl) pyrido [2, 3-d] pyrimidine-6-carboxylic acids and their derivatives. J Med Chem. 1975;18(1):74–9. - PubMed

LinkOut - more resources